Study to Test Safety and Effectiveness of Super-Bore 87F Aspiration Catheters for Treating Acute Blockages in Large Brain Arteries

What this Trial Is About

Researchers are evaluating the safety and effectiveness of the Super-Bore 87F Thrombosis Aspiration Catheter in treating acute intracranial large vessel occlusion, a serious type of acute ischemic stroke. This randomized controlled trial compares this new catheter with commonly used thrombectomy devices to see which is better at removing blood clots and restoring blood flow in the brain. Participants are randomly assigned to one of two groups one group receives mechanical thrombectomy using the Super-Bore 87F Thrombosis Aspiration Catheter, while the other group is treated with standard thrombectomy devices. The procedure is performed within 24 hours of stroke onset to remove the clot blocking major brain arteries. During the study, researchers will measure how often the first pass effect successful clot removal on the first attempt occurs within 5 minutes at the final angiography. They will also assess participants disability and recovery 90 days after the procedure using the modified Rankin Score. Participants will be monitored closely throughout to evaluate safety, treatment impact, and outcomes.

A Multicenter, Randomized Controlled Clinical Investigation to Evaluate the Safety and Effectiveness of the Super-Bore 8/7F Aspiration Catheters in the Treatment of Acute Intracranial Large Vessel Occlusion